FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial
GEICAM_CIBOMA试验结果显示,FOXC1表达可预测卡培他滨对三阴性乳腺癌患者的疗效
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-0338
Rojo, Federico; Taylor, Clive R; Barrios, Carlos; Torrecillas, Laura; Ruiz-Borrego, Manuel; Perez-Buira, Sandra; Bines, Jose; Guerrero-Zotano, Angel; Garcia-Saenz, Jose A; Torres, Roberto; de la Haba-Rodriguez, Juan; Ayala, Francisco; Gomez, Henry; Llombart, Antonio; Rodriguez de la Borbolla, Maria; Baena-Cañada, Jose Manuel; Barnadas, Agusti; Calvo, Lourdes; Herranz, Jesus; Rincon, Raul; Caballero, Rosalia; Bermejo, Begoña; Ray, Partha S; Martin, Miguel